Clinical use of HIV-1 resistance genotyping. Predictive factors of poor virological evolution in salvage treatments

To describe the use of genotype resistance testing (GRT) for virological failure in clinical practice, and the long-term clinical and virological evolution in patients for whom it is requested. To identify the predictive factors of virological failure in patients with antiretroviral (ARV) salvage th...

Full description

Saved in:

Bibliographic Details
Published in:	Enfermedades infecciosas y microbiología clínica Vol. 24; no. 4; pp. 225 - 231
Main Authors:	Riera-Jaume, Melcior, Peñaranda-Vera, María, Ribas-Blanco, Maria Angels, Murillas-Angoiti, Javier, Campins, Antoni, Salas-Aparicio, Ana, Leyes-García, María, Pareja-Bezares, Antonio, Pérez, José Luis, Villalonga-Pieras, Concepción
Format:	Journal Article
Language:	Spanish
Published:	Spain 01-04-2006
Subjects:	Adult Anti-HIV Agents - classification Anti-HIV Agents - pharmacology Anti-HIV Agents - therapeutic use CD4 Lymphocyte Count Drug Resistance, Viral - genetics Female Genotype HIV Infections - drug therapy HIV Protease Inhibitors - pharmacology HIV Protease Inhibitors - therapeutic use HIV-1 - drug effects HIV-1 - genetics Humans Male Microbial Sensitivity Tests - methods Nucleosides - pharmacology Nucleosides - therapeutic use Point Mutation Retrospective Studies Reverse Transcriptase Inhibitors - pharmacology Reverse Transcriptase Inhibitors - therapeutic use Risk Factors Salvage Therapy Treatment Failure Viral Load Virology - methods
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!